| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |